Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 6, 2002, Pages 875-880

  Hikosaka, Makoto ^a   Yuasa, Fumio ^a   Yuyama, Reisuke ^a   Mimura, Jun ^a   Kawamura, Akihiro ^a   Motohiro, Masayuki ^a   Iwasaki, Masayoshi ^a   Sugiura, Tetsuro ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II receptor blocker; Arterial baroreflex sensitivity; Heart failure; Sympathetic activity

Indexed keywords

ANGIOTENSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; NITRATE; NORADRENALIN; PHENYLEPHRINE; RENIN; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; AGED; ANGIOTENSIN BLOOD LEVEL; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEART FAILURE; HEART RATE; HUMAN; MALE; MUSCLE CONTRACTION; NORADRENALIN RELEASE; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; DRUG EFFECT; ELECTROCARDIOGRAPHY; FORWARD HEART FAILURE; HEMODYNAMICS; MIDDLE AGED;

ANTIHYPERTENSIVE AGENTS; BAROREFLEX; BENZIMIDAZOLES; CARDIAC OUTPUT, LOW; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; SYMPATHETIC NERVOUS SYSTEM; TETRAZOLES;

EID: 0036890925     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200212000-00008     Document Type: Article

References (31)

1. Dibner-Dunlap ME, Thames MD. Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ Res 1989;65:1526-35.
2. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Eng J Med 1971;285:877-83.
3. Goldstein RE, Beiser GD, Stampfer M, et al. Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circ Res 1975;36:571-8.
4. Ellenbogen KA, Mohanty PK, Szentpetery S, et al. Arterial baroreflex abnormalities in heart rate: Reversal after orthotopic cardiac transplantation. Circulation 1989;78:51-8.
5. Ferguson DW, Berg WJ, Roach PJ, et al. Effects of heart failure on baroreflex control of sympathetic neural activity. Am J Cardiol 1992;69:523-31.
6. Olivari MT, Levine TB, Cohn JN. Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure. J Am Coll Cardiol 1983;2:411-7.
7. Schwartz PJ, Vanoli E, Stramba-Badiale M, et al. Autonomic mechanisms and sudden death: New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988;78: 969-79.
8. Sander-Jensen K, Secher NH, Astrup A, et al. Angiotensin II attenuates reflex decrease in heart rate and sympathetic activity in man. Clin Physiol 1988;8:31-40.
9. Barron KW, Trapani AJ, Gordon FJ, et al. Baroreceptor denervation profoundly enhances cardiovascular responses to central angiotensin II. Am J Physiol 1989;257:H314-23.
10. Berenguer LM, Garcia-Estan J, Ubeda M, et al. Role of renin-angiotensin system in the impairment of baroreflex control heart rate in renal hypertension. J Hypertens 1991;9:1127-33.
11. Dibner-Dunlap ME, Smith ML, Kinugawa T, et al. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 1996;27:358-64.
12. Grassi G, Cattaneo BM, Seravelle G, et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 1997;96:1173-9.
13. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Eng J Med 1991;325:293-302.
14. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
15. Awan NA, Mason DT. Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure. Am Heart J 1996;131:177-85.
16. Xu L, Brooks VL. Sodium intake, angiotensin II receptor blockade, and baroreflex function in conscious rats. Hypertension 1997;29:450-7.
17. Weinstock M, Gorodetsky E. Comparison of the effects of angiotensin II, losartan, and enalapril on baroreflex control of heart rate in conscious rabbits. J Cardiovasc Pharmacol 1995;25:501-7.
18. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999;33:1442-52.
19. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: A quantitative method of assessing baroreflex sensitivity. Circ Res 1969;24:109-21.
20. Mark AL, Victor RH, Nerhed C, et al. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 1985;57:461-9.
21. Grassi G, Seravalle G, Calhoun DA, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994;90:248-53.
22. Voelker JR, Cobb SL, Bowsher RR. Improved HPLC radioimmunoassay for quantifying angiotensin II in plasma. Clin Chem 1994;40:1537-43.
23. Shibasaki Y, Mori Y, Tsutumi Y, et al. Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure. Clin Nephrol 1999;51:83-91.
24. Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995;92:3206-11.
25. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992;262:E763-78.
26. DiBona GF, Jones SY, Brooks VL. Ang II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol 1995;269:R1189-96.
27. Rajagopalan S, Kurz S, Munzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.
28. Liu JL, Zucker IH. Regulation of sympathetic nerve activity in heart failure: A role for nitric oxide and angiotensin II. Circ Res 1999;84:417-23.
29. Schnackenberg CG, Wilkins MR, Granger JP. Role of nitric oxide in modulation of the vasoconstrictor actions of angiotensin II in preglomerular and postglomerular vessels in dogs. Hypertension 1995;26:1024-9.
30. Hasking GJ, Esler MD, Jennings GL, et al. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nerve activity. Circulation 1986;73:615-21.
31. Davis D, Baily R, Zelis R. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Am J Physiol 1988;254:E760-6.